Ligand validation:2RHS

GAX: 1-{3-[(4-pyridin-2-ylpiperazin-1-yl)sulfonyl]phenyl}-3-(1,3-thiazol-2-yl)urea

GAX is a Ligand Of Interest in 2RHS designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2RHS_GAX_C_2	86%	5%	0.097	0.964	2.31	3.12	4	18	4	0	100%	1
2RHS_GAX_A_1	67%	8%	0.133	0.94	2.18	2.5	4	18	3	0	100%	1
2RHQ_GAX_A_352	82%	8%	0.113	0.969	1.52	3.02	3	20	2	0	100%	1
4P73_GAX_D_301	57%	68%	0.192	0.967	0.56	0.66	-	1	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.